These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Good clinical use of serum tumor markers]. Boussen H; el May M; Jerbi G; Rahal K; Benna F; Mtimet S; Ben Ayed F Tunis Med; 1998 Feb; 76(2):1020-6. PubMed ID: 9844536 [No Abstract] [Full Text] [Related]
3. [Criteria for using tumor markers. 2: Indications and interpretation]. Fateh-Moghadam VA; Stieber P Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968 [No Abstract] [Full Text] [Related]
4. Introduction to tumor markers from A to Z. Plaut D MLO Med Lab Obs; 2004 Aug; 36(8):22, 26. PubMed ID: 15366364 [No Abstract] [Full Text] [Related]
5. Serum alpha one antitrypsin in malignancy. Yemul VL; Kumthekar SN; Muley PR; Agrawal BR Indian J Cancer; 1987 Jun; 24(2):107-11. PubMed ID: 3500907 [No Abstract] [Full Text] [Related]
6. [Tumor markers--serologic parameters for monitoring and therapeutic control of cancer patients]. Birkmayer J Wien Med Wochenschr; 1988 Jun; 138(11-12):276-8. PubMed ID: 3176507 [TBL] [Abstract][Full Text] [Related]
7. [Tumor markers and TNM classification]. Ohkura H Gan To Kagaku Ryoho; 1998 Oct; 25(12):1981-4. PubMed ID: 9797825 [TBL] [Abstract][Full Text] [Related]
8. Continuous inappropriate use of serum tumour markers. Tran HA Intern Med J; 2005 Oct; 35(10):640-1; author reply 641. PubMed ID: 16207270 [No Abstract] [Full Text] [Related]
9. Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfalls. Gion M; Daidone MG Eur J Cancer; 2004 Nov; 40(17):2613-22. PubMed ID: 15541962 [TBL] [Abstract][Full Text] [Related]
10. [Tumor markers: theory or reality?]. Molina R; Filella X; Ballesta AM Med Clin (Barc); 1994 Feb; 102(5):189-95. PubMed ID: 8127170 [No Abstract] [Full Text] [Related]
11. Tumour markers - new aspects of an old discussion? Fleischhacker M; Beinert T Eur J Med Res; 1999 Apr; 4(4):144-8. PubMed ID: 10205289 [TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage]. Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935 [TBL] [Abstract][Full Text] [Related]
13. [A simple method of measuring serum sialic acid level as a neoplasm marker]. Tadeusiak W; Sadłowska B; Krawczyński MJ Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):845-8. PubMed ID: 3684762 [No Abstract] [Full Text] [Related]
14. Use of tumour markers in cancer diagnosis and treatment. Higgins C Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591 [TBL] [Abstract][Full Text] [Related]
15. [Quantification of serum antiproteases as a marker in neoplasms. A critical study of its usefulness]. Millán J; Senra A; Lorenzo A; López Sáez JJ Med Clin (Barc); 1988 Feb; 90(5):195-8. PubMed ID: 2451096 [No Abstract] [Full Text] [Related]
16. Biomarkers for the early detection of cancer: an inflammatory concept. Roy HK; Khandekar JD Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302 [No Abstract] [Full Text] [Related]
17. [Relationship between Noguchi's classification for small adenocarcinomas of the lung and tumor markers in serum]. Watanabe A; Watanabe T; Tabata T; Takahashi K; Abe T; Abe S; Sato M; Kusajima K Kyobu Geka; 2001 Oct; 54(11):917-20. PubMed ID: 11593727 [TBL] [Abstract][Full Text] [Related]
18. [Biological tumor markers]. Gattoni A; Catalano G; Papaleo G; Della Vittoria Scarpati M; Rippa A; Altucci P Clin Ter; 1989 Feb; 128(3):191-205. PubMed ID: 2524310 [TBL] [Abstract][Full Text] [Related]
19. Correlation of level of gangliosides in plasma with cancer in human patients. Mondal S; Saha S J Exp Clin Cancer Res; 2000 Sep; 19(3):317-27. PubMed ID: 11144525 [TBL] [Abstract][Full Text] [Related]